	Predicting complications after hepatectomy for hepatocellular carcinoma: a narrative review focused on liver failure. Front Oncol Zhang H, Cai J, Yang Z, Ye T, Zhao Z, Chen X, Wan J. PMID: 43005667 [PubMed]
	CT referrals and cancer detection in patients referred by general practitioners with non-specific symptoms and signs of cancer: A retrospective study. Acta Radiol Open Ohana NL, Axelsen J, Wilkinson MS, Graumann O, Sivesgaard K, Buus TW, Vedsted P, Midtgaard A, Greve SB, Larsen SKA. PMID: 43005528 [PubMed]
	Current and emerging strategies to enhance chemotherapeutic efficacy in pancreatic ductal adenocarcinoma. BMC Med Hackett D, Kane LE, Prina-Mello A, Maher SG. PMID: 43004418 [PubMed - indexed for MEDLINE]
	Exercise-containing multimodal prehabilitation on functional outcome of patients with hepatobiliary and pancreatic cancer after surgery: a meta-analysis. BMC Cancer She Z, Jiang Q, Lu W. PMID: 43004285 [PubMed - indexed for MEDLINE]
	Ras signaling in cancer: From molecular mechanisms to next-generation therapeutic inhibitors. Biochim Biophys Acta Rev Cancer Hossain J, Choudhury D, Bhattacharyya S, Vedeshachaitanya B, Malakar P. PMID: 43003238 [PubMed - as supplied by publisher]
	Controversies in NEN: An ENETS position statement on the diagnosis and treatment of mixed neuroendocrine/non-neuroendocrine neoplasms of the digestive system. J Neuroendocrinol Spada F, Kasajima A, de Mestier L, Luong TV, Marinoni I, Milione M, Sadanandam A, Speel EJ, Koumarianou A, Caruso D, Pascher A, Sorbye H. PMID: 43003098 [PubMed - indexed for MEDLINE]
	Towards precision oncology in pancreatic cancer: Diagnostic and prognostic biomarkers from conventional methods to liquid biopsy and artificial intelligence-based approaches. Biochem Biophys Res Commun Maghsoodi N, Ameri M, Absalan F, Esmaeili M, Ramezani A. PMID: 43002872 [PubMed - as supplied by publisher]
	Cancer Risks Associated With Germline BARD1 Pathogenic/Likely Pathogenic Variants: A Multicenter Study of 445 Families. JCO Precis Oncol Homer JP, Demeure MJ, Yao Y, Hanson K, Ramczyk B, Lichtenberg EC, Cohen SA, Crow K, Florido ME, Powell KP, Koerner CM, DeGrandchamp ME, Zrada C, Gonzales MB, Collier RA, Chien ES, Torres CB, Lin J, Sigsbee S, Smith SG, Adar TA, Berry DK, Gewandter K, Wright N, Senter L, Brown J, Baker MJ, Morse K, Scouten R, Brown SM, van den Berg D, Tran LB, Childers K, Gordon O, Bond E, Pagan B, Woo S, Mandich H, Nathan D, Karlan BY, Ku L, De Rosa D, Chang EY, Reed L, Brown EB, Patel G, Darabi S, BARD1 Collaborators. PMID: 43002722 [PubMed - indexed for MEDLINE]
	PancreaGuide for Computed Tomography Report Interpretation and Perioperative Consultation in Pancreatic Cancer: Development and Retrospective Evaluation of a Knowledge-Augmented Large Language Model Agent. J Med Internet Res Kuang T, Wang R, Zhang S, Sun Y, Zhou J, Wu Z, Peng B. PMID: 43002664 [PubMed - indexed for MEDLINE]
	Ecosystem Determinants of Therapeutic Resistance in Pancreatic Cancer: Implications for Precision Oncology. Cancer Invest Shahiwala AF. PMID: 43001337 [PubMed - as supplied by publisher]
	RNA sequencing and proteomic analysis of diagnostic biopsies from colorectal and pancreatic cancer. Biochem Biophys Rep Nordlund V, Haram M, Hofsli E, Røe OD, Davies CL, Mjelle R. PMID: 43001289 [PubMed]
	New-Onset Diabetes as a Red Flag for Pancreatic Cancer: From Metabolic Clues to Earlier Detection in Primary Care. Cureus Camacho-Flores L, Alvarez A, Bonet Vazquez R, Benet P, Alfonso García CB, Marti Del Rio M. PMID: 43001179 [PubMed]
	Quantitative fragility of reported association between aspirin use and hepatocellular carcinoma risk in metabolic dysfunction-associated steatotic liver disease: Letter to the editor on "Aspirin and hepatocellular carcinoma risk in metabolic dysfunction-associated steatotic liver disease: Nationwide cohort study with genetic risk analysis". Clin Mol Hepatol Zhang SJ, Gao G. PMID: 43001021 [PubMed - as supplied by publisher]
	Theranostic lipid nanocarriers for precision diagnosis and targeted therapy in pancreatic ductal adenocarcinoma. J Cancer Res Clin Oncol Nagdev S, Tantray J, Yadav MK, Patel A, Sharma S, Singh AK, Sharma M, Kumar D, Choudhary N, Kondaveeti SB. PMID: 43000459 [PubMed - indexed for MEDLINE]
	Feasibility study of habitat imaging based on DCE-MRI combined with clinical and imaging features for predicting lymph node metastasis in patients with pancreatic ductal adenocarcinoma. BMC Med Imaging Du YN, Hu DR, Chen M, Pan X, Zhang JG, Chen J. PMID: 43000231 [PubMed - indexed for MEDLINE]
	Messenger RNA vaccine platforms from molecular optimization to infectious disease and cancer immunotherapy: a narrative review. Transl Cancer Res Wang Q, Sun Z, Liu H. PMID: 42997904 [PubMed]
	Development and preliminary clinical characterization of an MDT-defined surgical-window framework for complex pancreatic cancer: a retrospective cohort study. J Gastrointest Oncol Li X, Ma D, Ma T, Wu S, Zhu J, Li T, Gao J. PMID: 42996876 [PubMed]
	Association between white blood cell-to-hemoglobin ratio and in-hospital mortality among critically ill patients with pancreatic cancer: a retrospective cohort study based on MIMIC-IV and eICU-CRD. J Gastrointest Oncol Song J, Zhang H, Li J, Pan T, Cheng T. PMID: 42996841 [PubMed]
	Neoadjuvant therapy-related skeletal muscle reduction and postoperative outcomes after gastrectomy for gastric cancer: a systematic review and meta-analysis. J Gastrointest Oncol Li L, Zhang J, Wang H, Gou C, Wang X, He Y, Tian Y. PMID: 42996835 [PubMed]
	Reassessing standard neoadjuvant gemcitabine plus S-1 for resectable pancreatic head cancer: a retrospective cohort study. J Gastrointest Oncol Kimura K, Sato S, Naito Z, Yamamoto H, Suzuki T, Kyogoku N, Katagiri H, Yamabuki T, Kato K, Takada M, Ambo Y, Hirano S. PMID: 42996581 [PubMed]

Articles 1 - 20 / 62125

Page 1 of 3107



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy